SecBot SecBot
SECBOTREPLAY Home › Report › LSTA

LSTA · 350M share resale registration

LISATA THERAPEUTICS, INC. · S-3 filed Nov 12, 2026 at 17:16 ET

At the news

BEARISHIMPACT 6/10

S-3 filed Nov 12, 2026 at 17:16 ET

Lisata Therapeutics filed an S-3 shelf registration to register 350,498,987 shares of common stock for resale by selling stockholders. The shares were issued in connection with the September 2026 acquisition of Marea Therapeutics and a concurrent $225 million private placement. The company will not receive any proceeds from the resale, but the registration enables former Marea stockholders and PIPE investors to sell their shares, creating potential overhang.

  • S-3 registers 350,498,987 shares for resale by selling stockholders, comprising 1,679,366 Merger Common Shares, 197,951,626 Merger Conversion Shares, and 150,867,995 Private Placement Conversion Shares.
  • Shares were issued in the September 2026 acquisition of Marea Therapeutics (stock-for-stock) and a concurrent $225 million PIPE at $1.49137 per share on an as-converted basis.
  • As of November 1, 2026, only 10,804,066 shares of common stock were outstanding, so the registered shares represent approximately 32x the current float on a pre-reverse-split basis.
  • Conversion of Series C Preferred Stock into common stock is expected on December 2, 2026, subject to stockholder approval and Nasdaq listing approval.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access